Pardaxin P 1 (9CI)(105184-54-1)
- Name: Pardaxin P 1 (9CI)
- Synonyms:1: PN:US20040162260 SEQID: 1 unclaimed sequence; 25: PN: US20060147442 SEQID: 26unclaimed sequence; 26: PN: WO2004110143 SEQID: 26 unclaimed sequence; 26: PN:WO2007047189 SEQID: 26 unclaimed sequence; 27: PN: WO0209738 SEQID: 26unclaimed sequence; 28: PN: US20070104722 SEQID: 26 unclaimed sequence; 30: PN:WO2005012492 SEQID: 41 unclaimed sequence; L-Glutamic acid,glycyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-leucyl-L-isoleucyl-L-prolyl-L-lysyl-L-isoleucyl-L-isoleucyl-L-seryl-L-seryl-L-prolyl-L-leucyl-L-phenylalanyl-L-lysyl-L-threonyl-L-leucyl-L-leucyl-L-seryl-L-alanyl-L-valylglycyl-L-seryl-L-alanyl-L-leucyl-L-seryl-L-seryl-L-serylglycyl-L-a-glutamyl-L-glutaminyl-
- Molecular Formula:C157H252 N36 O47
- Molecular Weight:
- CAS Registry Number:105184-54-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 33391-27-4/3-[3-(dimethylamino)propyl]-1-[(2-methoxybenzyl)(methyl)amino]-3-phenyl-1,3-dihydro-2H-indol-2-one
- 161510-45-8/benzyl [(2S,3S)-1-{[(2S,3R,4R)-4-(benzylamino)-5-{[(2S)-1-(benzylamino)-3-methyl-1-oxobutan-2-yl]amino}-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino}-3-methyl-1-oxopentan-2-yl]carbamate (non-preferred name)
- 61612-62-2/2-methoxy-4-{(E)-[(4-methylphenyl)imino]methyl}phenyl pyrrolidin-1-ylacetate hydrochloride
- 176548-70-2/3-Bromo-5-fluorobenzoic acid
- 68814-24-4/Safflower oil, polymer with benzoic acid, phthalic anhydride, trimethylolethane and tung oil
- 56980-14-4/5-Methoxy-2-(4-MethoxyphenylaMino)benzoic acid
- 16018-29-4/1-octyl-4-(1-phenylpropan-2-yl)piperazine dihydrochloride
- 64043-21-6/SA 4114
- 174957-52-9/D123 Protein
- 89460-92-4/tris(diphenylphenanthroline)cobalt(III)
- 5157-71-1/4-nitro-N-{2,2,2-trichloro-1-[(2,5-dimethylphenyl)amino]ethyl}benzamide
- 94004-50-9/N-tert-butyl-9-oxo-9H-fluorene-4-carboxamide
- 71011-17-1/Castor oil, polymer with dipropylene glycol, glycerol, maleic anhydride and phthalic anhydride
- 91696-13-8/Acetic acid, chloro-, sodium salt, reaction products with 4,5-dihydro-alpha-methyl-1H-imidazole-1-ethanol 2-norcoco alkyl derivs. and sodium hydroxide
- 75159-29-4/3-[({[(4-methylphenyl)amino]methyl}amino)methyl]quinazolin-4(3H)-one dihydrochloride
- 108278-71-3/3-[carbamoyl(nitroso)amino]propanoic acid
- 8055-26-3/Pregna-1,4-diene-3,20-dione,9-fluoro-11,17,- 21-trihydroxy-16-methyl-,(11â,16R)-,mixt. with 2,2-dichloro-N-[(1R,2R)-2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide
- 65324-03-0/Antibiotic FR 900012
- 23348-14-3/6-(3-methoxyphenyl)-4-phenyl-2-[2-(piperidin-1-yl)ethyl]pyridazin-3(2H)-one
- 105184-54-1/Pardaxin P 1 (9CI)
- 88392-04-5/methyl 4-(3-ethyl-3-hydroxymethyltriazen-1-yl)benzoate
- 67262-79-7/N-(2,6-dimethylphenyl)-N~2~-(2-methoxypropyl)glycinamide hydrochloride
- 6624-41-5/2,2-di-tert-butyl-1,1,1,3,3,3-hexamethyltrisilane
- 550-52-7/21H,23H-Porphine-7-propanoic acid, 3-carboxy-13-ethenyl-18-ethyl-7,8-dihydro-2,5,8,12,17-pentamethyl-, (7S,8S)-
- 15403-45-9/33DICARBOMETHOXYBENZIDINE
- 63302-94-3/bis(nonylphenyl) phenyl phosphate
- 6964-64-3/2-[(E)-2-(4-hydroxy-3-methoxy-phenyl)ethenyl]-1-methyl-quinolin-8-ol; sulfooxymethane
- 88799-71-7/2H-Pyrido(3,2-b)-1,4-oxazine, 3,4-dihydro-2,2-dimethyl-4-(1-phenylethyl)-
- 113-42-8/METHYLERGONOVINE
- 90170-29-9/Acetic acid, reaction products with 2-((2-aminoethyl)amino)ethanol, acetates (salts)